4//SEC Filing
Price P Schaefer 4
Accession 0001192482-11-000195
CIK 0001301081other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:32 PM ET
Size
9.2 KB
Accession
0001192482-11-000195
Insider Transaction Report
Form 4
Pharmasset IncVRUS
Price P Schaefer
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock, $.001 par value per share
2011-08-01$3.00/sh+20,000$60,000→ 403,283 total - Sale
Common Stock, $.001 par value per share
2011-08-01$120.15/sh−20,000$2,403,006→ 383,283 total - Exercise/Conversion
Stock Option (Right to Buy)
2011-08-01−20,000→ 225,957.33 totalExercise: $3.00Exp: 2014-08-10→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]This transaction is the result of standing instructions set forth in a Rule 10b5-1 plan previously established by the filer.
- [F2]Represents the weighted average sales price for price increments ranging from $117.43 to $122.36.
- [F3]The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- [F4]The options were granted on August 10, 2004. 25% were vested on the one-year anniversary of the grant and 6.25% became vested quarterly thereafter.
- [F5]Following this transaction, Mr. Price has 663,298.67 options remaining in total from all grants, including the 225,957.33 options reported above.
Documents
Issuer
Pharmasset Inc
CIK 0001301081
Entity typeother
Related Parties
1- filerCIK 0001397332
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:32 PM ET
- Size
- 9.2 KB